Syngene International Limited (SYNGENE) Share Analysis
NSE · Healthcare · Healthcare
Syngene International Limited (NSE: SYNGENE) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY Healthcare Index, NIFTY MidSmallcap 400. As of 21 Sep 2026, the share price was ₹369.00, market capitalisation ₹14,897 Cr, P/E 50.3, ROE 7.78%.
Get the AI verdict on SYNGENE: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
SYNGENE price and valuation
- Share price
- ₹369.00
- Market cap
- ₹14,897 Cr
- P/E ratio
- 50.3
- P/B ratio
- 3.08
- EPS
- ₹5.49
- Book value per share
- ₹120.00
- Dividend yield
- 0.34%
SYNGENE profitability and growth
- ROE
- 7.78%
- ROCE
- 9.99%
- Debt to equity
- 0.09
- Revenue growth (3 yr)
- 5%
- Revenue growth (5 yr)
- 11%
- Profit growth (3 yr)
- -8%
- Profit growth (5 yr)
- 0%
SYNGENE 52-week range
- 52-week high
- ₹678.95
- 52-week low
- ₹366.65
- Face value
- ₹10.00
SYNGENE shareholding pattern
- Promoters
- 52.59%
- FIIs
- 11.82%
- DIIs
- 28.01%
- Public
- 7.15%
Index membership: NIFTY 500, NIFTY Healthcare Index, NIFTY MidSmallcap 400, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.